BioCorRx (BICX) Non-Current Deffered Revenue (2013 - 2024)
BioCorRx recorded quarterly Non-Current Deffered Revenue of $4045.0 in Q1 2024, little changed quarter-over-quarter from $4045.0 in Q4 2023, and little changed year-over-year from $4045.0 in Q2 2023.
BioCorRx's Non-Current Deffered Revenue history runs 12 years deep, the most recent figure standing at $4045.0 for Q1 2024.
- In Q1 2024, Non-Current Deffered Revenue changed 0.0% year-over-year to $4045.0; the TTM figure through Mar 2024 stood at $4045.0 (changed 0.0% YoY), while the FY2023 annual figure was $4045.0, changed 0.0% from the prior year.
- Non-Current Deffered Revenue came in at $4045.0 for Q1 2024 at BioCorRx, roughly flat from $4045.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $1.2 million in Q2 2020 to a low of $4045.0 in Q4 2022.
- A 5-year average of $105104.3 and a median of $19954.0 in 2022 frame the typical range for Non-Current Deffered Revenue.
- Across the five-year window, Non-Current Deffered Revenue surged 584.03% in 2020 and sank 89.16% in 2022, its largest moves.
- BioCorRx's Non-Current Deffered Revenue stood at $65560.0 in 2020, then sank by 43.1% to $37301.0 in 2021, then tumbled by 89.16% to $4045.0 in 2022, then changed by 0.0% to $4045.0 in 2023, then changed by 0.0% to $4045.0 in 2024.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $4045.0, $4045.0, and $4045.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn | - |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn | - |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn | - |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn | - |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn | 86.28 Mn |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn | - |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn | - |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn | 142.66 Mn |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn | - |
| 10 | BioCorRx | - | - | 189,355.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 4,045.00 |
| Dec 31, 2023 | 4,045.00 |
| Sep 30, 2023 | 4,045.00 |
| Jun 30, 2023 | 4,045.00 |
| Mar 31, 2023 | 4,045.00 |
| Dec 31, 2022 | 4,045.00 |
| Sep 30, 2022 | 11,137.00 |
| Jun 30, 2022 | 19,954.00 |
| Mar 31, 2022 | 28,675.00 |
| Dec 31, 2021 | 37,301.00 |
| Sep 30, 2021 | 46,118.00 |
| Jun 30, 2021 | 54,935.00 |
| Mar 31, 2021 | 63,656.00 |
| Dec 31, 2020 | 72,281.00 |
| Sep 30, 2020 | 78,402.00 |
| Jun 30, 2020 | 87,219.00 |
| Mar 31, 2020 | 94,592.00 |
| Sep 30, 2019 | 139,604.00 |
| Jun 30, 2019 | 168,563.00 |
| Mar 31, 2019 | 197,207.00 |
| Dec 31, 2018 | 207,523.00 |
| Sep 30, 2018 | 245,935.00 |
| Jun 30, 2018 | 284,347.00 |
| Mar 31, 2018 | 342,822.00 |
| Dec 31, 2017 | 207,523.00 |
| Sep 30, 2017 | 416,582.00 |
| Jun 30, 2017 | 466,954.00 |
| Mar 31, 2017 | 556,564.00 |
| Dec 31, 2016 | 613,428.00 |
| Sep 30, 2016 | 722,526.00 |
| Jun 30, 2016 | 831,625.00 |
| Mar 31, 2016 | 939,537.00 |
| Dec 31, 2015 | 844,673.00 |
| Sep 30, 2015 | 180,684.00 |
| Jun 30, 2015 | 180,684.00 |
| Mar 31, 2015 | 1.01 Mn |
| Dec 31, 2014 | 1.19 Mn |
| Sep 30, 2014 | 1.36 Mn |
| Dec 31, 2013 | 741,723.00 |